Why no numbers are shown
Ranges for IGF-1 LR3 circulate in supplier and community material, but our own profile records that they are not backed by a published study: “These are community-reported ranges with no clinical trial behind them: no human dosing study of IGF-1 LR3 has been published.” We will not reprint a range as a dose calculation when nothing established it. See the IGF-1 LR3 profile for the full evidence picture.
Convert your IGF-1 LR3 dose
Vial
Result
Converted amount0.25 mg
Dose mass250 mcg
Concentration2,500 mcg/mL
Draw volume0.1 mL
U-100 syringe10 units
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
IGF-1 LR3 at a glance
Prolonged relative to native IGF-1; not established in humans
Half-life
9,117 Da
Molecular weight
subcutaneous, intramuscular
Routes
research only
Legal status